Release Date: 02/05/16 08:13 Summary: Quarterly Activities Report-TV2.AX Price Sensitive: No Download Document 112.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%